September 29, 2022

Volume XII, Number 272

Advertisement

September 29, 2022

Subscribe to Latest Legal News and Analysis

September 28, 2022

Subscribe to Latest Legal News and Analysis

September 27, 2022

Subscribe to Latest Legal News and Analysis

Biotechnology, Life Sciences, Food and Drug Law News

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

For hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis Twitter feed, and sign up for complimentary e-news bulletins.

Date Title Organization
29
Sep
MintzRx — Medicaid Best Price Value Based Purchasing Rules Took Effect July 1, 2022 Mintz
29
Sep
MintzRx — Pressure to Combat High Drug Prices Lands PBMs in the Hot Seat Mintz
29
Sep
MintzRx — Drug Pricing Update: The Inflation Reduction Act Mintz
28
Sep
4th Quarter 2022 Quick Hits for Plan Sponsors and Administrators Jackson Lewis P.C.
28
Sep
Tension Over Copay Assistance and Maximizer Programs Continues Mintz
28
Sep
MintzRx — Summer 2022 Enforcement Round-Up: Key Trends in Pharmacy Enforcement Actions Mintz
28
Sep
MintzRx — Digital Health Update: Federal Government Shows Growing Enforcement Interest in Online Prescribing of Controlled Substances Mintz
28
Sep
California Enacts Legal Protections for Cannabis Insurance Providers Wilson Elser Moskowitz Edelman & Dicker LLP
28
Sep
Mere Puffery vs False Advertising: Recent Trends ArentFox Schiff LLP
28
Sep
Developers Take Note: FDA Issues Clinical Decision Support Software Final Guidance Foley & Lardner LLP
28
Sep
New Report Outlines FDA’s Strategy to Ensure the Safety of Imported Produce Keller and Heckman LLP
27
Sep
DOJ Announces $900 Million Settlement Tied to Speaker Bureau Payments to Physicians Robinson & Cole LLP
27
Sep
FDA Is Accepting EUA Requests for Monkeypox Tests, But Time is of the Essence Mintz
27
Sep
Health Foods in China: New Rules Approving Functional Claims Keller and Heckman LLP
27
Sep
Last Call: Deadline for Requesting Alabama Medical Cannabis Applications Looms Bradley Arant Boult Cummings LLP
27
Sep
FDA Releases Food Safety Prevention Strategies Keller and Heckman LLP
26
Sep
Biogen Inc. Agrees to Pay $900 Million to Settle Allegations Related to Improper Physician Payments The U.S. Department of Justice
26
Sep
Issue-Spotting Hospital Activities that May Trigger FDA Regulatory Oversight [PODCAST] K&L Gates
26
Sep
Federal Appeals Court Upholds USDA Decision Not to Ban “Organic” Label for Hydroponics Keller and Heckman LLP
24
Sep
413 Pounds of Concealed Marijuana Intercepted by Cincinnati CBP U.S. Customs and Border Protection

Pages

Advertisement
Advertisement
Advertisement